These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10692719

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
    Salonen R, Ashford EA, Gibbs M, Hassani H.
    Int J Clin Pract Suppl; 1999 Aug; 105():16-24. PubMed ID: 10692718
    [Abstract] [Full Text] [Related]

  • 3. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N, Brautaset NJ, Reunanen M, Szirmai I, Ashford EA, Hassani H, Saiers J.
    Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
    [Abstract] [Full Text] [Related]

  • 4. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 5. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
    Natarajan S, Jabbour JT, Webster CJ, Richardson MS.
    Headache; 2004 Apr; 44(10):969-77. PubMed ID: 15546259
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P, Landy S, Richardson M, Ames M.
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results].
    Centonze V, Polito MB, Di Bari M, Fabbri L, Cassiano MA, Bassi A, Albano O.
    Clin Ter; 1995 Nov; 146(11):721-8. PubMed ID: 8720348
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
    Pini LA, Fabbri L, Cavazzuti L.
    Int J Clin Pharmacol Res; 1999 Nov; 19(2):57-64. PubMed ID: 10669900
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.